Question 1

What is Empagliflozin?

Accepted Answer

Empagliflozin belongs to a class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. This drug functions by blocking the reabsorption of glucose in the kidneys, which allows the body to eliminate sugar through urination.

By reducing the amount of sugar circulating in the blood, it helps maintain metabolic balance. It is used as a therapeutic tool to manage glucose levels and support the body's ability to regulate sugar.

Question 2

What is Empagliflozin used for?

Accepted Answer

Empagliflozin is used to treat:

Type 2 diabetes mellitus

Heart failure

Chronic kidney disease

Question 3

How does Empagliflozin work?

Accepted Answer

Mechanism of Action

Empagliflozin works by targeting the kidneys to help lower blood sugar levels in people with type 2 diabetes. In a healthy body, the kidneys filter glucose (sugar) out of the blood and then reabsorb most of it back into the bloodstream. Empagliflozin blocks a specific protein called sodium-glucose co-transporter 2 (SGLT2), which is responsible for this reabsorption process.

Glucose Removal

By blocking SGLT2, the medication prevents the kidneys from returning sugar to the blood. Instead, the excess sugar is passed out of the body through urination. This process helps lower overall blood glucose levels and may also lead to a slight reduction in blood pressure and weight due to the loss of sugar and associated fluids.

Heart and Kidney Protection

In addition to managing blood sugar, empagliflozin is used to reduce the risk of cardiovascular death and hospitalization in people with heart failure. It is also used to slow the progression of chronic kidney disease. While the exact ways it protects the heart and kidneys are still being studied, it is believed to work by reducing the workload on the heart and lowering the pressure within the filtering units of the kidneys.

Question 4

What are the brand names for Empagliflozin?

Accepted Answer

Empagliflozin is sold under the brand name Jardiance .

Question 5

What are the active ingredients in Empagliflozin?

Accepted Answer

The active ingredient in Empagliflozin is empagliflozin .

Question 6

What are the side effects of Empagliflozin?

Accepted Answer

Common side effects of Empagliflozin may include:

urinary tract infection

genital yeast infection

increased urination

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Empagliflozin?

Accepted Answer

Empagliflozin belongs to the SGLT2 inhibitor drug class.

Question 8

What is the dosage of Empagliflozin and how do I take it?

Accepted Answer

How to Take This Medication

Empagliflozin is taken by mouth, usually once a day. It is recommended to take the tablet in the morning. You may take this medication either with or without food.

To ensure the medication works effectively, try to take it at the same time every day. Follow the instructions on your prescription label carefully, and do not take more or less of the medication than prescribed.

Missed Dose

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take two doses at the same time to make up for a missed one.

Storage and Handling

Store the tablets at room temperature, away from moisture and heat. Keep the medication in its original container and out of reach of children.

Question 9

Is Empagliflozin safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Information regarding the use of empagliflozin during pregnancy is limited. Based on animal studies, the medication may cause harm to a developing fetus, specifically affecting kidney development during the second and third trimesters. Because of these potential risks, empagliflozin is usually not recommended for use during the last two trimesters of pregnancy.

If you become pregnant while taking this medication, notify your healthcare provider immediately. They will help determine the best course of action for managing your condition, as maintaining stable blood sugar levels is essential for a healthy pregnancy.

Breastfeeding

It is currently unknown if empagliflozin is excreted in human breast milk. However, because the drug could potentially cause serious side effects in a nursing infant, particularly related to kidney growth, healthcare providers generally advise against breastfeeding while using this medication. Discuss your options with your doctor to determine whether to stop breastfeeding or switch to a different treatment.

Question 10

What forms and strengths does Empagliflozin come in?

Accepted Answer

Empagliflozin is supplied as a film-coated tablet for oral administration. It is designed to be swallowed whole and is typically taken once daily, either with or without food.

This medication is not available in other formulations such as liquids, injections, or topical applications.

Question 11

What is the FDA approval status of Empagliflozin?

Accepted Answer

FDA Approval and Indications

Empagliflozin was first approved by the U.S. Food and Drug Administration (FDA) in 2014. It is currently indicated for several uses in adults:

Improving blood sugar control in people with type 2 diabetes, alongside diet and exercise.

Reducing the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.

Reducing the risk of cardiovascular death and hospitalization for heart failure.

Reducing the risk of sustained decline in kidney function, end-stage kidney disease, cardiovascular death, and hospitalization in adults with chronic kidney disease.

Safety Communications and Labeling Changes

The FDA has issued several safety communications regarding the class of drugs known as SGLT2 inhibitors, which includes empagliflozin:

Ketoacidosis: In 2015, the FDA revised labels to include warnings about the risk of ketoacidosis, a serious condition where the body produces high levels of blood acids. This can occur even if blood sugar levels are not significantly elevated.

Serious Urinary Tract Infections: Warnings were added regarding the risk of severe urinary tract infections, including urosepsis and pyelonephritis, which may require hospitalization.

Fournier’s Gangrene: The FDA has identified a rare but serious risk of necrotizing fasciitis of the perineum (Fournier’s gangrene), a life-threatening bacterial infection of the tissue under the skin surrounding the genital area.

Empagliflozin does not currently carry a Boxed Warning, the FDA's most serious type of warning.

Question 12

What should I know about Empagliflozin and weight loss?

Accepted Answer

How Empagliflozin Affects Weight

Empagliflozin belongs to a class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. This drug functions by blocking the reabsorption of glucose in the kidneys, which allows the body to eliminate sugar through urination.

By reducing the amount of sugar circulating in the blood, it helps maintain metabolic balance. It is used as a therapeutic tool to manage glucose levels and support the body's ability to regulate sugar.

Clinical Observations

In clinical studies, people taking empagliflozin for type 2 diabetes or heart failure frequently experienced a decrease in body weight. This weight loss is generally considered a secondary effect of the medication's primary function of managing blood sugar or heart health. It is intended to be used alongside a reduced-calorie diet and regular physical activity.

Important Considerations

Empagliflozin is not FDA-approved as a weight management or weight loss drug.

The amount of weight lost varies among individuals and may depend on other factors like diet and exercise.

Some initial weight loss may be due to the loss of fluids, as the medication has a mild diuretic effect when it increases sugar excretion.

Weight loss is typically more pronounced in people using the medication to manage type 2 diabetes.

Empagliflozin

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Brand Names

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Weight Loss Information

FAQ

Additional Resources

Support & Help Resources

Found an Error?